Five-year survival after Helicobacter pylori eradication in Alzheimer disease patients

Cognitive and Behavioral Neurology

Volumn 23, Issue 3, 2010, Pages 199-204

  Kountouras, Jannis ^a   Boziki, Marina ^a   Gavalas, Emmanouel ^a   Zavos, Christos ^a   Deretzi, Georgia ^b   Chatzigeorgiou, Stavros ^a   Katsinelos, Panagiotis ^a   Grigoriadis, Nikolaos ^a   Giartza Taxidou, Evangelia ^a   Venizelos, Ioannis ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

Author keywords

Alzheimer disease; dementia; Helicobacter pylori

Indexed keywords

ADOLESCENT; ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EVALUATION AND FOLLOW UP; FEMALE; GREECE; HELICOBACTER INFECTION; HUMAN; HYPOTHESIS; MALE; MINI MENTAL STATE EXAMINATION; MORTALITY; OUTCOME ASSESSMENT; PATIENT CODING; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SCHOOL CHILD; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT REFUSAL;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 77957586832     PISSN: 15433633     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNN.0b013e3181df3034     Document Type: Article

References (34)

1. Jalbert JJ, Daiello LA, Lapane KL. Dementia of the Alzheimer type. Epidemiol Rev. 2008;30:15-34. [PubMed: 18635578]
2. Wolfson C, Wolfson DB, Asgharian M, et al. A reevaluation of the duration of survival after the onset of dementia. N Engl J Med. 2001;344:1111-1116. [PubMed: 11297701]
3. Molsa PK, Marttila RJ, Rinne UK. Long-term survival and predictors of mortality in Alzheimer's disease and multi-infarct dementia. Acta Neurol Scand. 1995;91:159-164. [PubMed: 7793228]
4. Kinoshita J. Pathogens as a cause of Alzheimer's disease. Neurobiol Aging. 2004;25:639-640. [PubMed: 15172742]
5. Itzhaki RF, Wozniak MA, Appelt DM, et al. Infiltration of the brain by pathogens causes Alzheimer's disease. Neurobiol Aging. 2004;25:619-627. [PubMed: 15172740]
6. Robinson SR, Dobson C, Lyons J. Challenges and directions for the pathogen hypothesis of Alzheimer's disease. Neurobiol Aging. 2004; 25:629-637. [PubMed: 15172741]
7. Malaguarnera M, Bella R, Alagona G, et al. Helicobacter pylori and Alzheimer's disease: a possible link. Eur J Intern Med. 2004;15: 381-386. [PubMed: 15522573]
8. Kountouras J, Tsolaki M, Gavalas E, et al. Relationship between Helicobacter pylori infection and Alzheimer disease. Neurology. 2006;66:938-940. [PubMed: 19326283] (Pubitemid 43739779)
9. Kountouras J, Tsolaki M, Boziki M, et al. Association between Helicobacter pylori infection and mild cognitive impairment. Eur J Neurol. 2007;14:976-982. [PubMed: 17718688]
10. Kountouras J, Gavalas E, Zavos C, et al. Alzheimer's disease and Helicobacter pylori infection: defective immune regulation and apoptosis as proposed common links. Med Hypotheses. 2007;68: 378-388. [PubMed: 16979298]
11. Roubaud-Baudrom C, Krolak-Salmon P, Megraud F, et al. Helicobacter pylori chronic infection and Alzheimer disease: vascular or/ and inflammatory association? Helicobacter. 2009;14:366. (Abstract No: P05.16).
12. Kountouras J, Boziki M, Gavalas E, et al. Eradication of Helicobacter pylori may be beneficial in the management of Alzheimer's disease. J Neurol. 2009;256:758-767. [PubMed: 19240960]
13. Kountouras J, Boziki M, Gavalas E, et al. Increased cerebrospinal fluid Helicobacter pylori antibody in Alzheimer's disease. Int J Neurosci. 2009;119:765-777. [PubMed: 19326283]
14. Graham DY, Yamaoka Y, Malaty HM. Contemplating the future without Helicobacter pylori and the dire consequences hypothesis. Helicobacter. 2007;12(suppl 2):64-68. [PubMed: 17991179]
15. Markus HS, Mendall MA. Helicobacter pylori infection: a risk factor for ischaemic cerebrovascular disease and carotid atheroma. J Neurol Neurosurg Psychiatry. 1998;64:104-107. [PubMed: 9436737]
16. Kountouras J, Deretzi G, Zavos C, et al. Association between Helicobacter pylori infection and acute inflammatory demyelinating polyradiculoneuropathy. Eur J Neurol. 2005;12:139-143. [PubMed: 15679702]
17. Wilson RS, Aggarwal NT, Barnes LL, et al. Biracial population study of mortality in mild cognitive impairment and Alzheimer disease. Arch Neurol. 2009;66:767-772. [PubMed: 19506138]
18. Helzner EP, Scarmeas N, Cosentino S, et al. Survival in Alzheimer disease: a multiethnic, population-based study of incident cases. Neurology. 2008;71:1489-1495. [PubMed: 18981370]
19. Selhub J. The many facets of hyperhomocysteinemia: studies from the Framingham cohorts. J Nutr. 2006;136(6 suppl):1726S-1730S. [PubMed: 16702347]
20. Kountouras J, Gavalas E, Boziki M, et al. Helicobacter pylori may be involved in cognitive impairment and dementia development through induction of atrophic gastritis, vitamin B-12 folate deficiency, and hyperhomocysteinemia sequence. Am J Clin Nutr. 2007; 86:805-806. [PubMed: 17823449]
21. Mendall MA, Goggin PM, Molineaux N, et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J. 1994;71:437-439. [PubMed: 8011406]
22. Brunnstrom HR, Englund EM. Cause of death in patients with dementia disorders. Eur J Neurol. 2009;16:488-492. [PubMed: 19170740]
23. Kissler S, Hötte SD, Lankers D, et al. [Impact of vascular pathology on survival times of 173 dementia patients-Hachinski's ischemic score as a predictive tool for clinical purposes] [Article in German]. Z Gerontol Geriatr. 2008;41:51-55. [PubMed: 18286327]
24. Sevush S, Jy W, Horstman LL, et al. Platelet activation in Alzheimer disease. Archives Neurol. 1998;55:530-536. [PubMed: 9561982]
25. Casoli T, Di Stefano G, Giorgetti B, et al. Platelet as a physiological model to investigate apoptotic mechanisms in Alzheimer beta- amyloid peptide production. Mech Ageing Dev. 2008;129:154-162. PubMed: 18160097]
26. Mhatre M, Floyd RA, Hensley K. Oxidative stress and neuroin-flammation in Alzheimer's disease and amyotrophic lateral sclerosis: common links and potential therapeutic targets. J Alzheimers Dis. 2004;6:147-157. [PubMed: 15096698]
27. Bazan NG, Colangelo V, Lukiw WJ. Prostaglandins and other lipid mediators in Alzheimer's disease. Prostaglandins Other Lipid Mediat. 2002;68-69:197-210. [PubMed: 12432919]
28. Holmes C, Cunningham C, Zotova E, et al. Systemic inflammation and disease progression in Alzheimer disease. Neurology. 2009;73: 768-774. [PubMed: 19738171]
29. Kountouras J, Mylopoulos N, Chatzopoulos D, et al. Eradication of Helicobacter pylori may be beneficial in the management of chronic open-angle glaucoma. Archives Internal Medi. 2002;162:1237-1244. [PubMed: 12038941]
30. Paul J, Strickland S, Melchor JP. Fibrin deposition accelerates neurovascular damage and neuroinflammation in mouse models of Alzheimer's disease. J Exp Med. 2007;204:1999-2008. [PubMed: 17664291]
31. Pulido R, Jimenez-Escrig A, Orensanz L, et al. Study of plasma antioxidant status in Alzheimer's disease. European J Neurol. 2005; 12:531-535. [PubMed: 15958093]
32. Mangialasche F, Polidori MC, Monastero R, et al. Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment. Ageing Res Rev. 2009;8:285-305. [PubMed: 19376275]
33. Hoffmann O, Zipp F, Weber JR. Tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) in central nervous system inflammation. Mol Med 2009;87:753-763. [PubMed: 19449143]
34. Scarmeas N, Luchsinger JA, Mayeux R, et al. Mediterranean diet and Alzheimer disease mortality. Neurology. 2007;69: 1084-1093. [PubMed: 17846408]